Target intelligence / Profile preview

X antigen family, member 3 pseudogene (XAGE3P)

Target: XAGE3P
Molecular classification: Pseudogene, Cancer-testis antigen pseudogene, Other (does not fit standard molecular target families like receptor, enzyme, etc.)

Overview

X antigen family, member 3 pseudogene (ENSG00000229885) is a non-coding pseudogene located in the human genome. Pseudogenes are gene copies that have accumulated mutations preventing them from expressing functional proteins. The parental family, XAGE, is related to cancer-testis antigens expressed in a variety of tumors and some fetal tissues, but this pseudogene (a mutated, nonfunctional copy) does not encode a protein and is not known to act as a therapeutic target, enzyme, receptor, or similar molecule. Pseudogenes may participate in gene regulation at the RNA level (for example, by affecting mRNA stability, acting as miRNA sponges, or contributing to epigenetic regulation) in some cases, but this has not been described specifically for ENSG00000229885. There are no approved drugs, direct disease associations, or biomarker uses for this pseudogene. As such, it is not a therapeutic target.

Other names: XAGE3PXAGE-3 pseudogeneX antigen family member 3 pseudogene

Biological functions

No direct protein-coding function (by definition of a pseudogene)May contribute to gene regulation via RNA or DNA-level mechanisms (such as acting as a decoy for miRNAs, serving as template for noncoding RNAs, or minor effects on epigenetics)Other

Disease associations

Other (Potential indirect association, but no established disease roles; parent gene family (XAGE, GAGE) are cancer/testis antigens, but pseudogene itself not causally linked to disease)

Beyond the preview

Go deeper on X antigen family, member 3 pseudogene (XAGE3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on X antigen family, member 3 pseudogene (XAGE3P).

Explore the full profile